Copyright Reports & Markets. All rights reserved.

Global Oncology Based Molecular Diagnostics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Market Overview

    • 1.1 Oncology Based Molecular Diagnostics Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 PCR
      • 1.2.2 Multiplex PCR
      • 1.2.3 In Situ Hybridization
      • 1.2.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
    • 1.3 Market Analysis by Applications
      • 1.3.1 Breast Cancer
      • 1.3.2 Prostate Cancer
      • 1.3.3 Colorectal Cancer
      • 1.3.4 Cervical Cancer
      • 1.3.5 Other
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Abbott Laboratories
      • 2.1.1 Business Overview
      • 2.1.2 Oncology Based Molecular Diagnostics Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Abbott Laboratories Oncology Based Molecular Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Bayer Healthcare
      • 2.2.1 Business Overview
      • 2.2.2 Oncology Based Molecular Diagnostics Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Bayer Healthcare Oncology Based Molecular Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Becton Dickinson
      • 2.3.1 Business Overview
      • 2.3.2 Oncology Based Molecular Diagnostics Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Becton Dickinson Oncology Based Molecular Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Cepheid
      • 2.4.1 Business Overview
      • 2.4.2 Oncology Based Molecular Diagnostics Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Cepheid Oncology Based Molecular Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Dako
      • 2.5.1 Business Overview
      • 2.5.2 Oncology Based Molecular Diagnostics Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Dako Oncology Based Molecular Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Danaher Corporation
      • 2.6.1 Business Overview
      • 2.6.2 Oncology Based Molecular Diagnostics Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Danaher Corporation Oncology Based Molecular Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Gen Probe(Hologic)
      • 2.7.1 Business Overview
      • 2.7.2 Oncology Based Molecular Diagnostics Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Gen Probe(Hologic) Oncology Based Molecular Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Roche Diagnostics
      • 2.8.1 Business Overview
      • 2.8.2 Oncology Based Molecular Diagnostics Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Roche Diagnostics Oncology Based Molecular Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Siemens Healthcare
      • 2.9.1 Business Overview
      • 2.9.2 Oncology Based Molecular Diagnostics Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Siemens Healthcare Oncology Based Molecular Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Oncology Based Molecular Diagnostics Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Oncology Based Molecular Diagnostics Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Oncology Based Molecular Diagnostics Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Oncology Based Molecular Diagnostics Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Oncology Based Molecular Diagnostics Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Oncology Based Molecular Diagnostics Market Analysis by Regions

    • 4.1 Global Oncology Based Molecular Diagnostics Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Oncology Based Molecular Diagnostics Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Oncology Based Molecular Diagnostics Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Oncology Based Molecular Diagnostics Sales and Growth Rate (2014-2019)
    • 4.3 Europe Oncology Based Molecular Diagnostics Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Oncology Based Molecular Diagnostics Sales and Growth Rate (2014-2019)
    • 4.5 South America Oncology Based Molecular Diagnostics Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Oncology Based Molecular Diagnostics Sales and Growth Rate (2014-2019)

    5 North America Oncology Based Molecular Diagnostics by Country

    • 5.1 North America Oncology Based Molecular Diagnostics Sales, Revenue and Market Share by Country
      • 5.1.1 North America Oncology Based Molecular Diagnostics Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Oncology Based Molecular Diagnostics Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Oncology Based Molecular Diagnostics Sales and Growth Rate (2014-2019)
    • 5.3 Canada Oncology Based Molecular Diagnostics Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Oncology Based Molecular Diagnostics Sales and Growth Rate (2014-2019)

    6 Europe Oncology Based Molecular Diagnostics by Country

    • 6.1 Europe Oncology Based Molecular Diagnostics Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Oncology Based Molecular Diagnostics Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Oncology Based Molecular Diagnostics Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Oncology Based Molecular Diagnostics Sales and Growth Rate (2014-2019)
    • 6.3 UK Oncology Based Molecular Diagnostics Sales and Growth Rate (2014-2019)
    • 6.4 France Oncology Based Molecular Diagnostics Sales and Growth Rate (2014-2019)
    • 6.5 Russia Oncology Based Molecular Diagnostics Sales and Growth Rate (2014-2019)
    • 6.6 Italy Oncology Based Molecular Diagnostics Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Oncology Based Molecular Diagnostics by Country

    • 7.1 Asia-Pacific Oncology Based Molecular Diagnostics Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Oncology Based Molecular Diagnostics Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Oncology Based Molecular Diagnostics Revenue and Market Share by Country (2014-2019)
    • 7.2 China Oncology Based Molecular Diagnostics Sales and Growth Rate (2014-2019)
    • 7.3 Japan Oncology Based Molecular Diagnostics Sales and Growth Rate (2014-2019)
    • 7.4 Korea Oncology Based Molecular Diagnostics Sales and Growth Rate (2014-2019)
    • 7.5 India Oncology Based Molecular Diagnostics Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Oncology Based Molecular Diagnostics Sales and Growth Rate (2014-2019)

    8 South America Oncology Based Molecular Diagnostics by Country

    • 8.1 South America Oncology Based Molecular Diagnostics Sales, Revenue and Market Share by Country
      • 8.1.1 South America Oncology Based Molecular Diagnostics Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Oncology Based Molecular Diagnostics Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Oncology Based Molecular Diagnostics Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Oncology Based Molecular Diagnostics Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Oncology Based Molecular Diagnostics Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Oncology Based Molecular Diagnostics by Countries

    • 9.1 Middle East and Africa Oncology Based Molecular Diagnostics Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Oncology Based Molecular Diagnostics Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Oncology Based Molecular Diagnostics Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Oncology Based Molecular Diagnostics Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Oncology Based Molecular Diagnostics Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Oncology Based Molecular Diagnostics Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Oncology Based Molecular Diagnostics Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Oncology Based Molecular Diagnostics Sales and Growth Rate (2014-2019)

    10 Global Oncology Based Molecular Diagnostics Market Segment by Type

    • 10.1 Global Oncology Based Molecular Diagnostics Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Oncology Based Molecular Diagnostics Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Oncology Based Molecular Diagnostics Revenue and Market Share by Type (2014-2019)
    • 10.2 PCR Sales Growth and Price
      • 10.2.1 Global PCR Sales Growth (2014-2019)
      • 10.2.2 Global PCR Price (2014-2019)
    • 10.3 Multiplex PCR Sales Growth and Price
      • 10.3.1 Global Multiplex PCR Sales Growth (2014-2019)
      • 10.3.2 Global Multiplex PCR Price (2014-2019)
    • 10.4 In Situ Hybridization Sales Growth and Price
      • 10.4.1 Global In Situ Hybridization Sales Growth (2014-2019)
      • 10.4.2 Global In Situ Hybridization Price (2014-2019)
    • 10.5 Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Growth and Price
      • 10.5.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Sales Growth (2014-2019)
      • 10.5.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Price (2014-2019)

    11 Global Oncology Based Molecular Diagnostics Market Segment by Application

    • 11.1 Global Oncology Based Molecular Diagnostics Sales Market Share by Application (2014-2019)
    • 11.2 Breast Cancer Sales Growth (2014-2019)
    • 11.3 Prostate Cancer Sales Growth (2014-2019)
    • 11.4 Colorectal Cancer Sales Growth (2014-2019)
    • 11.5 Cervical Cancer Sales Growth (2014-2019)
    • 11.6 Other Sales Growth (2014-2019)

    12 Oncology Based Molecular Diagnostics Market Forecast (2019-2024)

    • 12.1 Global Oncology Based Molecular Diagnostics Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Oncology Based Molecular Diagnostics Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Oncology Based Molecular Diagnostics Market Forecast (2019-2024)
      • 12.2.2 Europe Oncology Based Molecular Diagnostics Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Oncology Based Molecular Diagnostics Market Forecast (2019-2024)
      • 12.2.4 South America Oncology Based Molecular Diagnostics Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Oncology Based Molecular Diagnostics Market Forecast (2019-2024)
    • 12.3 Oncology Based Molecular Diagnostics Market Forecast by Type (2019-2024)
      • 12.3.1 Global Oncology Based Molecular Diagnostics Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Oncology Based Molecular Diagnostics Market Share Forecast by Type (2019-2024)
    • 12.4 Oncology Based Molecular Diagnostics Market Forecast by Application (2019-2024)
      • 12.4.1 Global Oncology Based Molecular Diagnostics Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Oncology Based Molecular Diagnostics Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Molecular diagnosis of tumor refers to the molecular biological diagnosis technology with nucleic acid or protein as the core, which is an important method for early diagnosis of tumor.

      Scope of the Report:
      The worldwide market for Oncology Based Molecular Diagnostics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
      This report focuses on the Oncology Based Molecular Diagnostics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      Market Segment by Manufacturers, this report covers
      Abbott Laboratories
      Bayer Healthcare
      Becton Dickinson
      Cepheid
      Dako
      Danaher Corporation
      Gen Probe(Hologic)
      Roche Diagnostics
      Siemens Healthcare

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia etc.)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      PCR
      Multiplex PCR
      In Situ Hybridization
      Isothermal Nucleic Acid Amplification Technology (INAAT)

      Market Segment by Applications, can be divided into
      Breast Cancer
      Prostate Cancer
      Colorectal Cancer
      Cervical Cancer
      Other

      The content of the study subjects, includes a total of 15 chapters:
      Chapter 1, to describe Oncology Based Molecular Diagnostics product scope, market overview, market opportunities, market driving force and market risks.
      Chapter 2, to profile the top manufacturers of Oncology Based Molecular Diagnostics, with price, sales, revenue and global market share of Oncology Based Molecular Diagnostics in 2017 and 2018.
      Chapter 3, the Oncology Based Molecular Diagnostics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
      Chapter 4, the Oncology Based Molecular Diagnostics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
      Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
      Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
      Chapter 12, Oncology Based Molecular Diagnostics market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
      Chapter 13, 14 and 15, to describe Oncology Based Molecular Diagnostics sales channel, distributors, customers, research findings and conclusion, appendix and data source.

      Buy now